Skip to content
Clinical Trials – home
Sponsor

Sab Biotherapeutics Inc.

United States 2100 East 54th Street North, 57104-5509, United States

About the sponsor

Clinical research activity is centered on Type 1 diabetes, with attention to newly diagnosed Stage 3 disease and the preservation of insulin-producing beta cells in the pancreas.

  • Autoimmune diabetes
  • Beta-cell preservation
  • Newly diagnosed Stage 3 Type 1 diabetes

The sponsor’s work in this area reflects a therapeutic focus on slowing disease progression and addressing the underlying immune-mediated loss of pancreatic function.

About Specializations

Sab Biotherapeutics Inc. runs clinical trials in conditions such as Type 1 diabetes mellitus, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

A Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease

Registered drug
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Sodium Chloride
  • Sponsor:Sab Biotherapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.